Skip to main content
. 2009 Jul 6;53(9):4015–4018. doi: 10.1128/AAC.00590-09

TABLE 2.

MICs of various drugs against M. chelonae ATCC 35752, M. chelonae 9917, M. chelonae 9917 expressing mspA (9917/pZS01), and M. chelonae ATCC 35752 expressing mspA (ATCC/pZS01)a

Drug MIC (μg ml−1) against:
ATCC 35752 ATCC/pZS01 9917 9917/pZS01
AMP >500 >500 >500 >500
KAN 50 ND 10 ND
STR 200 250 10-20 10
VAN 5 5-10 >500 25
CLA 25-50 50 >250 25
AZI 500 500 500 500
HYG >500 ND >500 ND
ERY 20-25 0.25 500 1
RIF 25 5 >500 100
EMB >500 25 >500 250
CHL >500 50 >500 50
TOB 25-50 ND 25 ND
GEN 7.5 7.5 15 20
INH >400 >400 >400 >400
ETH >400 50 >400 50
PZA >500 ND >500 ND
TET 50 5-10 >500 25
LIN 25 5 100 1
CIP 1.5 2.5 5 1
NOR 5 ND 5 ND
a

MICs were determined using the colorimetric resazurin microtiter assay in 7H9-oleic acid-albumin-dextrose-catalase broth at 30°C (16), and results were confirmed by visually scanning for growth. All assays were performed on well-dispersed bacteria and repeated at least three times on independent culture batches. AMP, ampicillin; AZI, azithromycin; CHL, chloramphenicol; CIP, ciprofloxacin; CLA, clarithromycin; EMB, ethambutol; ERY, erythromycin; ETH, ethionamide; GEN, gentamicin; HYG, hygromycin; INH, isoniazid; KAN, kanamycin; LIN, linezolid; NOR, norfloxacin; PZA, pyrazinamide; RIF, rifampin; STR, streptomycin; TET, tetracycline; TOB, tobramycin; VAN, vancomycin; ND, not determined.